查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1722661

2025 年至 2033 年抗酸剂市场报告（依药物类别、剂型、配销通路和地区）

Antacids Market Report by Drug Class, Formulation Type, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球抗酸剂市场规模达 72 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 97 亿美元，2025-2033 年期间的成长率 (CAGR) 为 3.4%。市场正在经历成长，主要是因为零售药局的扩张、对非处方药的偏好以及患有胃食道逆流 (GERD) 的患者数量的增加推动了市场的成长。

抗酸剂市场分析：

主要市场驱动因素：全球患有胃食道逆流症 (GERD) 的人数正在增加，这刺激了对抗酸剂的需求。这是推动市场成长的关键因素之一。

主要市场趋势：主要参与者推出的西瓜薄荷、水果麦片和草莓奶昔等调味和咀嚼型抗酸药对抗酸药市场收入产生了积极影响。

地理趋势：由于医疗支出增加、人口老化和医疗保健产业扩张，亚太地区是抗酸剂最大的区域市场。

关键参与者：抗酸剂产业的一些主要市场参与者包括雅培实验室、阿斯特捷利康公司、拜耳公司、勃林格殷格翰国际有限公司、雷迪博士实验室有限公司、葛兰素史克公司、强生公司、辉瑞公司、宝洁公司、利洁时集团、赛诺菲公司、太阳製药工业有限公司、武田药品工业有限公司等。

挑战与机会：抗酸剂市场的挑战在于存在治疗胃酸倒流的替代疗法，而机会则在于新兴市场和治疗消化问题的创新配方。

抗酸剂市场趋势：

胃食道逆流症（GERD）的影响

  • 美国国家医学图书馆 2022 年的报告称，2019 年有 7.8395 亿人受到 GERD 的影响。遭受 GERD 折磨的人越多，对抗酸剂的需求就越大。人们认为，治疗酸性体质的最佳方法是使用抗酸剂，因为它们具有多种特性。人们意识到抗酸剂可以快速缓解症状，而且其易于获取，进一步促进了抗酸剂市场的成长。

老年人口增加导致人口结构变化

老年人逐渐认识到抗酸剂的重要性，因为它们能快速缓解酸性。因此，他们经常购买或服用抗酸剂来治疗这些消化问题。可以说，人口老化程度越高的国家，其抗酸剂的全球销售量就越高。根据世界卫生组织（WHO）2022年的报告，到2030年和2050年，每6个人中就有1人年龄在60岁或以上。全球60岁以上人口也将从2020年的14亿增加到21亿。

由于非处方药 (OTC) 易于获取，人们对其的依赖性日益增强

非处方药物在世界各地很受欢迎，用于治疗轻微症状，这也刺激了对抗酸剂的需求。抗酸剂可透过药局、杂货店和线上平台轻鬆取得，因此在自我药疗中发挥着至关重要的作用。抗酸剂具有成本效益和节省时间的优点，非常适合当今的人们。 IMARC集团的研究报告提到，到2032年，全球非处方药（OTC）市场规模将达到2,759亿美元。

抗酸剂市场细分：

按毒品类别分类：

  • 质子帮浦抑制剂
  • H2拮抗剂
  • 酸中和剂
  • 促动力剂

质子帮浦抑制剂占大部分市场份额

质子帮浦抑制剂非常有效可靠，每个人都希望它能减少胃酸和消化不良。医疗保健专业人员根据胃酸倒流的严重程度开出这些药物，从而提高了其销售量。主要参与者正在扩大他们的市场，因为他们知道人们正在逐渐了解质子帮浦抑制剂对身体的正面影响。例如，大元製药于 2022 年在韩国推出了其首个质子帮浦抑制剂药物 Escorten。

依配方类型分类：

  • 药片
  • 液体
  • 粉末
  • 其他的

平板电脑占据产业最大份额

易于储存、运输和管理是平板电脑提供的一些优点，使其在个人中非常受欢迎。服用药片非常方便，因为可以在任何地方或旅途中使用水轻鬆服用。无论是在办公室、家中或旅行，人们都可以透过片剂药物快速缓解胃酸或消化不良。与液体或粉末配方类型相比，片剂的保质期延长被视为另一个好处。抗酸剂市场上存在的各种片剂配方，如咀嚼片、缓释片和泡腾片，进一步创造了强大的消费者群体。

依配销通路分类：

  • 医院药房
  • 零售药局
  • 其他的

零售药局是主要的细分市场

首先，世界各地的城市、郊区和农村都有大量的零售药局。抗酸剂作为非处方药非常受欢迎，零售药局是购买抗酸剂的重要管道。其次，零售药局提供多种抗酸药物，可以满足不同患者的喜好和需求。第三，零售药局市场主要竞争对手专注于收购和扩张以扩大其影响力。 Medly Pharmacy 于 2021 年收购 Pharmaca 以提供 360 度药房服务就是一个例子。

按地区划分：

  • 北美洲
  • 美国
  • 加拿大
  • 亚太
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
  • 中东和非洲

亚太地区引领市场，占据抗酸剂市场最大份额

该报告还对所有主要区域市场进行了全面的分析，包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告显示，亚太地区占据市场领先地位。

印度和中国等人口稠密的国家是该地区最大的抗酸剂市场，因为这些国家正在经历生活方式的转变和西方饮食习惯，这通常会导致胃酸倒流和消化不良。此外，由于该地区老龄人口极易出现消化问题，因此被视为抗酸剂市场近期的机会。与此相符的是，亚太地区有许多关键参与者，他们竞争激烈，并专注于合作和收购以扩大市场。印度製药公司雷迪博士实验室 (Dr. Reddy's Laboratories) 于 2024 年从 Amyris Inc. 收购了 MenoLabs，以满足亚太地区人民不断变化的需求。

竞争格局：

市场研究报告也对市场竞争格局进行了全面的分析。也提供了所有主要抗酸剂公司的详细资料。抗酸剂产业的一些主要市场参与者包括：

  • 雅培实验室
  • 阿斯特捷利康公司
  • 拜耳公司
  • 勃林格殷格翰国际股份有限公司
  • 雷迪博士实验室有限公司
  • 葛兰素史克公司
  • 强生公司
  • 辉瑞公司
  • 宝洁公司
  • 利洁时集团
  • 赛诺菲公司
  • 太阳製药工业有限公司
  • 武田药品工业株式会社。

（请注意，这仅代表部分公司名单，完整名单已在报告中提供。）

新配方和产品变体的开发由主要参与者透过研究和开发 (R&D) 活动完成。他们正在推出水果谷物等口味的抗酸药物，以满足消费者不断变化的需求。顶级公司正在利用发展中国家人民对胃肠道健康的认识不断提高这一机会。他们也着眼于收购市场上的小型企业，同时透过抗酸剂市场的最新发展创造机会。使用数位健康解决方案是主要的帮助方法，使他们能够提供更好的健康结果。阿斯特捷利康公司于 2023 年 11 月推出了一个这样的例子，该公司成立了健康科技公司 Evinova，提供先进的数位健康解决方案。

本报告回答的关键问题

  • 抗酸剂市场有多大
  • 2025-2033年全球抗酸剂市场的预期成长率是多少
  • 推动全球抗酸剂市场的关键因素有哪些
  • COVID-19 对全球抗酸剂市场有何影响
  • 根据药物类别，全球抗酸剂市场如何划分
  • 根据剂型，全球抗酸剂市场如何划分
  • 根据配销通路，全球抗酸剂市场如何划分
  • 全球抗酸剂市场的主要区域有哪些
  • 全球抗酸剂市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 抗酸剂市场有多大？ 2025 年至 2033 年期间全球抗酸剂市场的预期成长率为何？
  • 推动全球抗酸剂市场发展的关键因素有哪些？
  • COVID-19 对全球抗酸剂市场有何影响？
  • 根据药物类别，全球抗酸剂市场是如何分類的？
  • 根据配方类型，全球抗酸剂市场是如何分類的？
  • 根据配销通路，全球抗酸剂市场如何分布？
  • 全球抗酸剂市场的主要地区有哪些？
  • 全球抗酸剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球抗酸剂市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依药品类别

  • 质子帮浦抑制剂
  • H2拮抗剂
  • 酸中和剂
  • 促动力剂

第七章：市场区隔：依配方类型

  • 药片
  • 液体
  • 粉末
  • 其他的

第八章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • AstraZeneca plc
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Pfizer Inc.
    • Procter & Gamble Company
    • Reckitt Benckiser Group PLC
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
Product Code: SR112025A5082

The global antacids market size reached USD 7.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.4% during 2025-2033. The market is experiencing growth mainly because of the expansion of retail pharmacies, preference for OTC drugs, and rising number of patients experiencing gastroesophageal reflux disease (GERD) are impelling the growth of the market.

Antacids Market Analysis:

Major Market Drivers: People suffering from GERD is increasing around the world, which is catalyzing the demand for antacids. This represents one of the key factors propelling the market growth.

Key Market Trends: The launch of flavored and chewable antacids drugs by key players like watermelon mint, fruity cereals, and strawberry milkshake is positively impacting the antacids market revenue.

Geographical Trends: Asia Pacific is the largest regional market for antacids because of the rising healthcare expenditure, aging population, and healthcare sector expansion.

Key Players: Some of the major market players in the antacids industry include Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., among many others.

Challenges and Opportunities: Challenges in the antacids market are the presence of alternative treatment for acid reflux, while opportunities lie in emerging markets and innovative formulations to treat digestive issues.

Antacids Market Trends:

Gastroesophageal reflux disease's (GERD) impact

  • 783.95 million people were impacted by GERD in 2019 claimed by the report of the National Library of Medicine 2022. The more people going through the suffering of GERD, the more it is driving the demand for antacids. The best treatment for acidity is thought to be antacids because of their several qualities. Individuals are aware about the quick relief provided by antacids and their easy accessibility is further contributing to the antacids market growth.

Changing demographics because of rising geriatric population

Elderly people are understanding the importance of antacids because of their quick relief qualities from acidity. They are, as a result, a regular consumer or buyer of antacids to manage these digestive issues. It may be said that nations with increased aging population rates can have higher sales of antacids worldwide. As claimed by the World Health Organization's (WHO) report of 2022, 1 individual out of 6 will be of 60 years in age or over by 2030 and by 2050. The global population of those aged 60 and over will also reach 2.1 billion, up from 1.4 billion in 2020.

Rising reliance on over the counter (OTC) medicines due to their ease of availability

Non-prescribed remedies are highly preferred in the world to cure mild symptoms, which is catalyzing the antacids demand. Antacids are easily available via pharmacies, grocery stores, and online platforms and as a result play a crucial role in self-medication purposes. The cost-effectiveness and time saving benefits provided by antacids are making them highly suitable for people nowadays. The IMARC Group's research report mentions that the global market for over the counter (OTC) drugs will reach US$ 275.9 Billion by 2032.

Antacids Market Segmentation:

Breakup by Drug Class:

  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
  • Pro-Motility Agents

Proton pump inhibitors accounts for the majority of the market share

Proton pump inhibitors are so effective and reliable that everyone wants them to cut down on stomach acid and indigestion. Healthcare professionals prescribed them as per the severity of acid reflux, leading to their higher sales. Key players are expanding their market as they know people are gaining knowledge about the positive impact of proton pump inhibitors in the body. For instance, Daewon Pharmaceutical introduced its first proton pump inhibitor medicine in Korea in 2022, known as Escorten.

Breakup by Formulation Type:

  • Tablet
  • Liquid
  • Powder
  • Others

Tablet holds the largest share of the industry

Easy storage, transportation, and administration are some benefits provided by tablets make them highly preferable among individuals. Tablets are hassle-free, as they can be easily consumed with water anywhere or on the go. Whether at office, home, or travel, people can get quick relief from acidity or indigestion through tablet drugs. The extended shelf life of tablets is viewed as another benefit compared to liquid or powder formulation type. Various tablets formulations present in the antacids market like chewable, delayed release, and effervescent are further creating a strong consumer base.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Retail pharmacies represent the leading market segment

In the first place, cities, suburbs, and rural areas all have numerous retail pharmacies around the world. Antacids as OTC drugs are highly popular & retail pharmacies are a significant outlet to purchase antacids. Secondly, the inclusion of a wide variety of antacids drugs in retail pharmacies can cater to several patients according to their preferences and demands. Thirdly, the focus of leading competitors in the retail pharmacy market on acquisition & expansion to increase their reach. The acquisition of Pharmaca by Medly Pharmacy in 2021 to deliver 360-degrees pharmacy services is one such example.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Asia Pacific leads the market, accounting for the largest antacids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific enjoys the leading position in the market.

The densely populated countries like India and China are the largest markets for antacids in this region, as these countries are undergoing lifestyle shifts and Western food habits, which generally results in acid reflux and indigestion. Moreover, aging population in the region is viewed as an antacids market recent opportunities due to their high susceptibility to digestive issues. In line with this, lots of key players are present in the Asia Pacific region that are highly competitive and focus on partnerships and acquisition to expand their market. This was done by Dr. Reddy's Laboratories, a pharma company in India, when it acquired MenoLabs from Amyris Inc. in 2024 to cater to the evolving needs of people in the Asia Pacific region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major antacids companies have also been provided. Some of the major market players in the antacids industry include:

  • Abbott Laboratories
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Procter & Gamble Company
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited.

(Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.)

The development of new formulations and product variants is done by key players through research and development (R&D) activities. They are introducing antacid drugs with flavors such as Fruity Cereal to meet the evolving demands of consumers. Top companies are taking advantage of elevated awareness about gastrointestinal health among people in developing countries. They are also eyeing on acquiring small businesses in the market while creating opportunities via antacids market recent developments. Using the digital health solutions is the main help method, enabling them to provide better health results. One such example was presented by AstraZeneca in November 2023, which it launched Evinova, a health-tech business, to offer advanced digital health solutions.

Key Questions Answered in This Report

  • 1.How big is the antacids market?
  • 2.What is the expected growth rate of the global antacids market during 2025-2033?
  • 3.What are the key factors driving the global antacids market?
  • 4.What has been the impact of COVID-19 on the global antacids market?
  • 5.What is the breakup of the global antacids market based on the drug class?
  • 6.What is the breakup of the global antacids market based on the formulation type?
  • 7.What is the breakup of the global antacids market based on the distribution channel?
  • 8.What are the key regions in the global antacids market?
  • 9.Who are the key players/companies in the global antacids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Antacids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Proton Pump Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 H2 Antagonist
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Acid Neutralizers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Pro-Motility Agents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Formulation Type

  • 7.1 Tablet
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Liquid
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Powder
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Dr. Reddy's Laboratories Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GlaxoSmithKline plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Procter & Gamble Company
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Reckitt Benckiser Group PLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sun Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Takeda Pharmaceutical Company Limited
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Antacids Market: Major Drivers and Challenges
  • Figure 2: Global: Antacids Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Antacids Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Antacids Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Antacids Market: Breakup by Formulation Type (in %), 2024
  • Figure 6: Global: Antacids Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Antacids Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Antacids (Proton Pump Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Antacids (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Antacids (H2 Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Antacids (H2 Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Antacids (Acid Neutralizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Antacids (Acid Neutralizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Antacids (Pro-Motility Agents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Antacids (Pro-Motility Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Antacids (Tablet) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Antacids (Tablet) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Antacids (Liquid) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Antacids (Liquid) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Antacids (Powder) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Antacids (Powder) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Antacids (Other Formulation Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Antacids (Other Formulation Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Antacids (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Antacids (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Antacids (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Antacids (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Antacids (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Antacids (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Antacids Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Antacids Industry: SWOT Analysis
  • Figure 80: Global: Antacids Industry: Value Chain Analysis
  • Figure 81: Global: Antacids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antacids Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Antacids Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 3: Global: Antacids Market Forecast: Breakup by Formulation Type (in Million USD), 2025-2033
  • Table 4: Global: Antacids Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Antacids Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Antacids Market: Competitive Structure
  • Table 7: Global: Antacids Market: Key Players